PubMed Health⌕ Search

Biomedical subjects

J D'Nicuola

Publications and source records attributed to J D'Nicuola.

2 recordsLinked to original sources

Methodologic considerations in the interpretation of postmortem carboxyhemoglobin concentrations.

The interpretation of postmortem carboxyhemoglobin (COHb) concentrations can have major implications even when COHb is not the direct cause of death. Much litigation may hinge on the length of time an individual was alive during the fire. Therefore, the reliability of an analytical method to measure COHb, ranging from low to sub-lethal levels, is critical to the proper interpretation of results. This study used 40 blood specimens from fire deaths and 15 blood specimens from non-fire deaths to compare COHb levels obtained from a spectrophotometric method (IL 482 CO-Oximeter; CO-Ox) with a reference gas chromatographic method (GC). Since spectrophotometric methods are influenced by the amount of total hemoglobin (Hb) present in the blood, multiple saline dilutions of specimens were performed to yield Hb as low as 1g/dl. For GC COHb concentrations < 5% and Hb > or = 4g/dl, the average and median ratios of CO-Ox COHb to GC COHb concentrations were 2.8 and 2.6 respectively. These ratios were 8.0 and 6.8 respectively when Hb < 4g/dl. At GC COHb levels ranging from 5 to 40% and Hb > or = 4g/dl, the average and median ratios were 1.6 and 1.0 respectively. These ratios were correspondingly 2.1 and 1.9 when Hb < 4 g/dl. These data clearly indicate COHb can be influenced by the analytical methods used.

Carbon Monoxide↗

Evaluation of six commercial amphetamine and methamphetamine immunoassays for cross-reactivity to phenylpropanolamine and ephedrine in urine.

We evaluated six commercially available amphetamine (A) and methamphetamine (MA) immunoassays for their relative cross-reactivities to isomers of phenylpropanolamine (PPA) and ephedrine (E) in urine: Syva EMIT, Abbott fluorescence polarization (FPIA), Roche, and Diagnostic Products Corporation (DPC) radioimmunoassays for A and MA. Two stereoisomers of PPA and four stereoisomers of E were tested using (1) drug-free urine spiked at 1,000 mg/L or 100 mg/L of each compound and (2) 60 clinical urine specimens not containing A or MA but having varying amounts of PPA and/or E. Specimens responding greater than the 1-mg/L A or MA cutoff were defined as positive. All specimens spiked at 100 mg/L were negative by all immunoassays. All specimens spiked at 1,000 mg/L were positive by EMIT and negative by FPIA, Roche A, and DPC A; 1,000 mg/L/-E and d-pseudoephedrine were also positive by Roche MA and DPC MA. Three of the 60 clinical specimens tested positive by EMIT and one specimen tested positive by DPC A and DPC MA.

Amphetamine↗